These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676 [No Abstract] [Full Text] [Related]
3. Treatment of leprosy with Lampren (B.663 Geigy). De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089 [No Abstract] [Full Text] [Related]
4. [Treatment of leprosy in children]. Scappini JF; Harvey W Arch Argent Pediatr; 1970 Dec; 68(10):367-9. PubMed ID: 5508181 [No Abstract] [Full Text] [Related]
5. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks. Ji B Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368 [No Abstract] [Full Text] [Related]
6. Single-dose treatment for single lesion leprosy; histopathological observations. Shinde A; Khopkar U; Pai VV; Ganapati R Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099 [No Abstract] [Full Text] [Related]
7. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R; Revankar CR; Pai VV; Kingsley S Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related]
8. Single-dose treatment for paucibacillary leprosy; field implications. Revankar CR; Pai VV; Samy MS; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415 [No Abstract] [Full Text] [Related]
9. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV; Bulchand HO; Revankar CR; Ganapati R Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
10. Acute renal failure and multidrug therapy for leprosy. Nishioka Sde A Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):259-60. PubMed ID: 9251601 [No Abstract] [Full Text] [Related]
12. Regarding Brasil, et al.'s adverse effects in leprosy's WHO/MDT and paramedic's role in leprosy control program. Cunha Mda G; Schettini AP; Pereira ES; Pedrosa VL; Cruz RC; Sadahiro M Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):257-9. PubMed ID: 9251600 [No Abstract] [Full Text] [Related]
13. Studies on the treatment of leprosy with a synthesized thiocarbanilide derivative L-4. Lew J; Chang CH; Choi TK Yonsei Med J; 1968; 9(1):24-37. PubMed ID: 5715900 [No Abstract] [Full Text] [Related]
14. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I; Cartel JL; Grosset JH Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [TBL] [Abstract][Full Text] [Related]
15. Risk of relapse in leprosy after fixed-duration multidrug therapy. Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of single dose multidrug therapy for the treatment of single-lesion paucibacillary leprosy. Single-lesion Multicentre Trial Group. Indian J Lepr; 1997; 69(2):121-9. PubMed ID: 9290963 [TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolones and their adverse effects. Girdhar BK Indian J Lepr; 1993; 65(1):69-79. PubMed ID: 8463726 [No Abstract] [Full Text] [Related]